CareTrust REIT (CTRE) is a Real Estate company in the Reit Healthcare Facilities industry. It has a market capitalization of $9.03B, a trailing price-to-earnings ratio of 25.1 and a free-cash-flow yield of 4.9%. Over the most recent reported fiscal year, revenue grew 61.8% and free cash flow per share grew 22.0%. Nama's AI scorecard rates it Buy, 5.9 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Buy · 5.9/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Middle · +0.7% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-12.4%
How far the last close sits under the highest price of the past five years.
Market cap
$9.03B
Trailing P/E
25.1
Price / book
2.0
Price / sales
15.8
FCF yield
4.9%
Dividend yield
4.1%
Gross margin
96.4%
Operating margin
56.8%
Net margin
78.5%
Revenue growth (YoY)
+61.8%
Revenue growth (3-yr annual)
+25.4%
EPS growth (YoY)
+19.5%
FCF/share growth (YoY)
+22.0%
Beta
0.8
Exchange
NYSE
Sector
Real Estate
Industry
Reit Healthcare Facilities
CTRE earnings
Next report: Feb 18, 2027 (Q4 2026, EPS estimate $0.44).
Beat the EPS estimate in 0 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 5, 2026
$0.41
$0.43
-4.7%
—
Q2 2026
Aug 6, 2026
$0.39
$0.39
+0.0%
$122.85M
Q1 2026
May 7, 2026
$0.36
$0.37
-2.7%
$118.05M
Q4 2025
Feb 12, 2026
$0.36
$0.38
-5.3%
$107.47M
CTRE analyst price target
Median target $43.00 from 14 analysts, ranging $41.00 – $49.00.
Nama's AI scorecard currently rates CareTrust REIT Buy (5.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CTRE's P/E ratio?
CareTrust REIT trades at a trailing price-to-earnings ratio of 25.1.
When does CTRE report earnings?
CareTrust REIT's next scheduled report is on Feb 18, 2027. Analysts expect EPS of $0.44.
What is the CTRE price target?
The median analyst price target from 14 analysts is $43.00, with a range of $41.00 – $49.00.
Is CTRE Shariah compliant?
Nama's AAOIFI-style screen reads CareTrust REIT as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.